Using real-world data to justify coverage for digital health solutions
Today’s most innovative companies are leveraging digital health data solutions to deliver...
Today’s most innovative companies are leveraging digital health data solutions to deliver...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclus...